Cargando…

Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation

The aim of this work was to evaluate the effect of two chemically different edge activators, i.e., Tween(®) 80 and sodium deoxycholate, on (i) the physical, mechanical, and biological properties of ultradeformable vesicles, and (ii) the administration of naproxen sodium-loaded multidrug ultradeforma...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinaro, Roberto, Gagliardi, Agnese, Mancuso, Antonia, Cosco, Donato, Soliman, Mahmoud E., Casettari, Luca, Paolino, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955705/
https://www.ncbi.nlm.nih.gov/pubmed/31816840
http://dx.doi.org/10.3390/pharmaceutics11120644
_version_ 1783486989634371584
author Molinaro, Roberto
Gagliardi, Agnese
Mancuso, Antonia
Cosco, Donato
Soliman, Mahmoud E.
Casettari, Luca
Paolino, Donatella
author_facet Molinaro, Roberto
Gagliardi, Agnese
Mancuso, Antonia
Cosco, Donato
Soliman, Mahmoud E.
Casettari, Luca
Paolino, Donatella
author_sort Molinaro, Roberto
collection PubMed
description The aim of this work was to evaluate the effect of two chemically different edge activators, i.e., Tween(®) 80 and sodium deoxycholate, on (i) the physical, mechanical, and biological properties of ultradeformable vesicles, and (ii) the administration of naproxen sodium-loaded multidrug ultradeformable vesicles for the transdermal route in order to obtain therapeutically meaningful drug concentrations in the target tissues and to potentiate its anti-inflammatory effect by association with the antioxidant drug idebenone. The results obtained in this investigation highlighted a synergistic action between naproxen and idebenone in the treatment of inflammatory disease with a more pronounced anti-inflammatory effect in multidrug ultradeformable vesicles compared to the commercial formulation of Naprosyn(®) gel. Systems made up of Tween(®) 80 appeared to be the most suitable in terms of percutaneous permeation and anti-inflammatory activity due to the greater deformability of these vesicles compared to multidrug ultradeformable vesicles with sodium deoxycholate. Our findings are very encouraging and suggest the use of these carriers in the topical treatment of inflammatory diseases.
format Online
Article
Text
id pubmed-6955705
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69557052020-01-23 Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation Molinaro, Roberto Gagliardi, Agnese Mancuso, Antonia Cosco, Donato Soliman, Mahmoud E. Casettari, Luca Paolino, Donatella Pharmaceutics Article The aim of this work was to evaluate the effect of two chemically different edge activators, i.e., Tween(®) 80 and sodium deoxycholate, on (i) the physical, mechanical, and biological properties of ultradeformable vesicles, and (ii) the administration of naproxen sodium-loaded multidrug ultradeformable vesicles for the transdermal route in order to obtain therapeutically meaningful drug concentrations in the target tissues and to potentiate its anti-inflammatory effect by association with the antioxidant drug idebenone. The results obtained in this investigation highlighted a synergistic action between naproxen and idebenone in the treatment of inflammatory disease with a more pronounced anti-inflammatory effect in multidrug ultradeformable vesicles compared to the commercial formulation of Naprosyn(®) gel. Systems made up of Tween(®) 80 appeared to be the most suitable in terms of percutaneous permeation and anti-inflammatory activity due to the greater deformability of these vesicles compared to multidrug ultradeformable vesicles with sodium deoxycholate. Our findings are very encouraging and suggest the use of these carriers in the topical treatment of inflammatory diseases. MDPI 2019-12-03 /pmc/articles/PMC6955705/ /pubmed/31816840 http://dx.doi.org/10.3390/pharmaceutics11120644 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Molinaro, Roberto
Gagliardi, Agnese
Mancuso, Antonia
Cosco, Donato
Soliman, Mahmoud E.
Casettari, Luca
Paolino, Donatella
Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title_full Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title_fullStr Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title_full_unstemmed Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title_short Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
title_sort development and in vivo evaluation of multidrug ultradeformable vesicles for the treatment of skin inflammation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955705/
https://www.ncbi.nlm.nih.gov/pubmed/31816840
http://dx.doi.org/10.3390/pharmaceutics11120644
work_keys_str_mv AT molinaroroberto developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT gagliardiagnese developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT mancusoantonia developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT coscodonato developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT solimanmahmoude developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT casettariluca developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation
AT paolinodonatella developmentandinvivoevaluationofmultidrugultradeformablevesiclesforthetreatmentofskininflammation